HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corrigendum to "Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway". [Toxicology and Applied Pharmacology 292 (2016) 19-29].

AuthorsLina Gu, Xufeng Tao, Youwei Xu, Xu Han, Yan Qi, Lina Xu, Lianhong Yin, Jinyong Peng
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 380 Pg. 114708 (Oct 01 2019) ISSN: 1096-0333 [Electronic] United States
PMID31401032 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: